Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.61 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16553587 | 0.77 | ERN1 (0.41) | ERN1MCL1MEN1LMNATHRB | |
| SCHEMBL20670553 | 0.76 | ERN1 (0.57) | ERN1TTRMCL1 | |
| SCHEMBL1527177 | 0.76 | ERN1 (1.00) | ERN1TTRCYP1A2CYP2C9HIF1A | |
| SCHEMBL32690998 | 0.75 | ERN1 (0.40) | ERN1TTRCYP1A2CYP2C9HIF1A | |
| SCHEMBL6903290 | 0.70 | ERN1 (0.50) | ERN1TTRMEN1KMT2ATDP1 | |
| SCHEMBL95555 | 0.70 | ERN1 (0.56) | ERN1MCL1MEN1LMNATHRB | |
| Formaldehyde SCHEMBL28061059 | 0.69 | TTR (0.45) | ERN1TTRTPMTPKM | |
| SCHEMBL31005049 | 0.69 | ERN1 (0.48) | ERN1MCL1MEN1LMNATHRB | |
| SCHEMBL22897458 | 0.67 | ERN1 (0.57) | ERN1 | |
| SCHEMBL22982394 | 0.67 | ERN1 (0.57) | ERN1TTRMCL1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4631532-A1 | PREPARATION METHOD FOR EMBOLIZATION MICROSPHERES | Shanghai Intervascular MedTech Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| WO-2024146444-A1 | PREPARATION METHOD FOR EMBOLIZATION MICROSPHERES | 上海拓脉医疗科技有限公司 | 2024-07-11 | — | — | WO | claimed |
| CN-118286496-A | Preparation method of embolism microsphere | 上海拓脉医疗科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2024017165-A1 | METHOXYPOLYETHYLENE GLYCOL-POLY(LACTIC-CO-GLYCOLIC ACID)-POLYLYSINE-BASED DEVELOPING POROUS MICROSPHERE, PREPARATION METHOD, AND USE | 森心(上海)科技有限公司 | 2024-01-25 | — | — | WO | claimed |
| CN-117323459-A | Developable embolism microsphere and preparation method and application thereof | 至微(深圳)医学科技有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-115487342-B | Self-developing absorbable embolism microsphere and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116440315-A | Multi-mode developed gelatin sponge microsphere and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116251225-A | Developing embolism microsphere and processing method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2023-06-13 | — | — | CN | claimed |
| EP-3492110-B1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2023-03-08 | — | — | EP | claimed |
| CN-110950981-B | Radiopaque polymers | 生物兼容英国有限公司 | 2023-02-17 | — | — | CN | claimed |
| EP-3041515-A1 | RADIOPAQUE POLYMERS | Biocompatibles Uk Ltd. (GB) | 2016-07-13 | — | — | EP | claimed |
| US-20160193367-A1 | Imageable Polymers | BIOCOMPATIBLES UK LTD (GB) | 2016-07-07 | — | — | US | claimed |
| CN-105517582-A | Imageable polymers | BIOCOMPATIBLES UK LTD | 2016-04-20 | — | — | CN | claimed |
| CN-105517581-A | Radiopaque polymers | BIOCOMPATIBLES UK LTD | 2016-04-20 | — | — | CN | claimed |
| WO-2015033093-A9 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2016-04-07 | — | — | WO | claimed |
| US-20150110722-A1 | IMAGEABLE POLYMERS | Boston Scientific Medical Device Limited (IE) | 2015-04-23 | — | — | US | claimed |
| WO-2015033093-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2015-03-12 | — | — | WO | claimed |
| WO-2015033092-A1 | IMAGEABLE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2015-03-12 | — | — | WO | claimed |
| EP-1390336-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2004-02-25 | — | — | EP | claimed |
| WO-2002096849-A1 | METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2002-12-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150110722-A1 | IMAGEABLE POLYMERS | BRDT, BRD3, BRD2 | ERN1 3538/4885TTR 4872/4885MCL1 363/4885 |
| US-20160193367-A1 | Imageable Polymers | VHL, FLT4, FLT1 | ERN1 1786/4885TTR 3226/4885MCL1 582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.